Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
about
Immune checkpoint blockade in infectious diseases.Predictive factors of response to immunotherapy-a review from the Spanish Melanoma Group (GEM).PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy?Perspective on immune oncology with liquid biopsy, peripheral blood mononuclear cells, and microbiome with non-invasive biomarkers in cancer patients.High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.Investigational PD-1 inhibitors in HL and NHL and biomarkers for predictors of response and outcome.Immune checkpoint inhibitors in advanced non-small cell lung cancer.Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade.CD4 and CD8 T lymphocyte interplay in controlling tumor growth.Gene Expression Signatures Characterized by Longitudinal Stability and Interindividual Variability Delineate Baseline Phenotypic Groups with Distinct Responses to Immune Stimulation.[Distribution and Clinical Significance of CTLA-4, PD-1 and PD-L1 in Peripheral Blood of Patients with Small Cell Lung Cancer].LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer.An Isolated TCR αβ Restricted by HLA-A*02:01/CT37 Peptide Redirecting CD8+ T Cells To Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines.The Peripheral and Intratumoral Immune Cell Landscape in Cancer Patients: A Proxy for Tumor Biology and a Tool for Outcome Prediction.Immunotherapy in previously treated non-small cell lung cancer (NSCLC).Immune Monitoring of Cancer Patients Prior to and During CTLA-4 or PD-1/PD-L1 Inhibitor Treatment.Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimen.Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma.Next generation immune-checkpoints for cancer therapy.Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemiaFuture prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistanceBiomarkers for Immune Checkpoint Inhibitors in MelanomaBiomarkers for predicting efficacy of PD-1/PD-L1 inhibitorsCirculating T Cell Subpopulations Correlate With Immune Responses at the Tumor Site and Clinical Response to PD1 Inhibition in Non-Small Cell Lung Cancer
P2860
Q41921732-DFB47073-7854-46B5-BD25-696C8C95CF2DQ47101836-BCC87D62-8208-4851-8086-B2AD0B78E11DQ47120629-137654A7-351E-4A91-A98C-D99114F0C4D2Q47137043-DF094791-DC93-43E3-8F8E-2429C276B795Q47219905-428F0524-8B4D-4F39-BA1F-36FA9FC1C1EFQ47225234-28A9F826-9F4D-4EED-AC24-05CDF463D6EFQ47329066-4AC9E7CA-7DED-44F7-8E64-5F938E0607C0Q47563451-C6A35461-A87F-4A27-8970-5E1C819E3E92Q47958949-79379D04-D978-4E82-9A2C-F861A2B655F8Q48185876-8B6D1CEB-14B4-48B5-8691-0EF02EFDE83EQ48204941-70CFC1E2-A35A-47A1-A7DE-2BC4B00D181AQ49790343-3BE99A9A-504C-4394-BBF5-337927045343Q50034376-7AFC0DB5-4B57-4574-97D0-AD476220DE2CQ52648005-CC51D9A5-6931-43C7-945A-BD7117920A10Q52679182-15CC42B5-5C92-4A05-A1AE-2EF61C15F3D4Q52723409-3CAE676D-241C-4296-9225-56225EBF9394Q55114350-61E2DED4-F8A6-4F5F-A544-2EAA5A1FBD77Q55293126-511075DF-52A0-4D16-8415-033E8EAED6F6Q55358698-B9374B18-9501-43E1-8BB6-FE02AD27B636Q55383705-22DAFD24-CBA9-41C2-B3FB-A227987174F5Q57138588-A5B6B5F0-419F-4BDE-BF4D-4A72DC5BE8B7Q57167969-B9A2861B-A950-4829-ADC6-32CBBF5A167CQ57175477-4924DE96-ECF2-4C2A-B49D-543D6DAA886CQ58713932-F87C7DDA-C304-4502-8B2D-0BF35923B3F9Q58801896-CD40273F-90D6-4CEF-B7D0-1FD60161188F
P2860
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Proliferation of PD-1+ CD8 T c ...... erapy in lung cancer patients.
@en
type
label
Proliferation of PD-1+ CD8 T c ...... erapy in lung cancer patients.
@en
prefLabel
Proliferation of PD-1+ CD8 T c ...... erapy in lung cancer patients.
@en
P2093
P2860
P356
P1476
Proliferation of PD-1+ CD8 T c ...... herapy in lung cancer patients
@en
P2093
Alice O Kamphorst
Chao Zhang
Fadlo R Khuri
Gabriel L Sica
Lydia Koenig
Madhusmita Behera
Megan McCausland
Nikita T Patel
P2860
P304
P356
10.1073/PNAS.1705327114
P407
P577
2017-04-26T00:00:00Z